US EditionMore than 50 conservative leaders sign letter against Trump drug pricing policy codification
Conservative leaders warn the plan would import price controls, reduce innovation, and limit access to new cures, urging Congress to reject the policy despite bipartisan support.
- Trump announced that dozens of commonly used prescription drugs will be available at dramatic discounts through a new website, but details are lacking.
- Lawmakers criticized the lack of transparency and called for pharmaceutical benefit managers to act as fiduciaries to prevent profiteering at the expense of patient care.
8 Articles
8 Articles
Conservative Heavyweights Pan Trump’s ‘Socialist’ Drug Pricing Plan
Susan Walsh/APA group of more than four dozen conservative and free-market activists penned a letter to members of Congress Thursday opposing the Trump administration’s new drug pricing model.The letter, sent to members of Congress, argued that the White House’s “most favored nation” drug pricing model released late last week would “import socialist price controls and values into our country.” It also suggests the program will reduce global comp…
Coalition Warns Congress Against Codifying Trump’s Drug-pricing Scheme
A coalition of free-market and conservative groups is urging Congress to reject a bill codifying Most Favored Nation price controls on drugs. ... The post Coalition Warns Congress Against Codifying Trump’s Drug-pricing Scheme appeared first on The New American.
Group of conservative leaders trash Trump’s 'socialist' proposal
A group of over 50 conservative leaders has come together to speak out against Donald Trump's new pricing proposal, according to The Hill, tarring the idea as "socialist" and urging Congress to reject it.Per The Hill's report from Thursday, the coalition of leaders from "conservative and free-market organizations" signed off on a letter to Congress opposing Trump's "most favored nation" pricing proposal for pharmaceutical drugs. The proposal cal…
More than 50 conservative leaders sign letter against Trump drug pricing policy codification
A coalition of more than 50 leaders of conservative and free-market organizations signed a letter to members of Congress, opposing codifying President Trump’s MFN drug pricing policy model into law.
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
